Biodefense Market Analysis, Size, Growth, Share, Outlook & Forecast to 2027
The global biodefense market size is expected to reach USD 19.9 billion by 2027, expanding at a CAGR of 5.9%, according to a new report by Grand View Research, Inc. Biodefense can be briefly defined as comprehensive measures (identification, planning, and preparedness) taken to rehabilitate the biosecurity of a country concerning biological threats or infectious diseases that can be easily used as a bioweapon to instigate social destruction and bioterrorism. Biological threats can be naturally occurring, accidental, or deliberate in origin. Factors like the presence of favorable government initiatives, increasing investment by private players, and the growing prevalence of various viral agents are fueling the market growth. Previous incidents of bioterrorism caused by viral agents like anthrax, smallpox, botulism have made biodefense a major focus area for advancements by countries to prevent bioterrorism. In 2017, the Centre for Disease Control and Prevention (CDC) stated that they had tracked more than 170 unique diseases globally and also identified outbreaks in more than 190 countries. In addition, according to the WHO, around 6, 50,000 people die of respiratory diseases associated with seasonal flu annually. Repeated outbreaks of the Zika and Ebola virus have coerced state governments to construct and strategize biodefense programs that will assist in planning and responding during future outbreaks. In 2018, the U.S government announced and issued the National Biodefense Strategy to manage the risk of biological incidents by detecting and containing biothreats at its source, promoting biomedical
innovation, and improving emergency response. These factors are expected to boost market growth over the forecast period. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/wearablemedical-devices-market Biodefense Market Report Highlights
The anthrax segment dominated the market in 2019. These bioagents possess a high risk of the threat, can last long in the environment, and can be released easily into the environment
Others product segment which includes Zika, Ebola and Marburg’s virus is expected to reciprocate highest CAGR over the forecast period due to rising outbreaks of diseases
North America dominated the market in 2019 owing to the presence of high federal funding, technological advancements, and growing awareness among the population
Asia Pacific is expected to reciprocate the highest CAGR over the forecast period owing to growing investment in R&D activities and the increasing threat of biowarfare.
Biodefense Market Segmentation Grand View Research has segmented the global biodefense market on the basis of product and region: Biodefense Product Outlook (Revenue, USD Million, 2016 - 2027) Anthrax
Smallpox
Botulism
Radiation/nuclear
Others
Biodefense Regional Outlook (Revenue, USD Million, 2016 - 2027) North America
o
The U.S.
o
Canada
Europe o
The U.K.
o
Germany
o
France
o
Spain
o
Italy
Asia Pacific o
India
o
Japan
o
China
Latin America o
Brazil
o
Mexico
o
Argentina
Middle East & Africa o
South Africa
Get Sample Copy of Report @ https://www.grandviewresearch.com/industryanalysis/wearable-medical-devices-market/request/rs1
List of Key Players of Biodefense Market XOMA Corporation
Altimmune Inc.
Emergent Biosolutions Inc.
Dynavax Technologies Corporation
SIGA Technologies
Elusys Therapeutics Inc.
Ichor Medical Systems
Dynport Vaccine Company
Cleveland Biolabs
Bavarian Nordic
Ology Bioservices
Alnylam Pharmaceuticals Inc.
Table of Content Chapter 1 Methodology and Scope 1.1 Market Segmentation & Scope
1.1.1 Product 1.1.2 Regional Scope 1.1.3 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 Gvr’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details Of Primary Research 1.4 Information Or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis (Model 1) 1.7 List Of Secondary Sources 1.8 List Of Primary Sources 1.9 List Of Abbreviations 1.10 Objectives 1.10.1 Objective - 1: 1.10.2 Objective - 2: 1.10.3 Objective - 3: 1.10.4 Objective - 4: Chapter 2 Executive Summary 2.1 Market Outlook Chapter 3 Biodefense Market: Variables, Trends, & Scope 3.1 Market Segmentation And Scope 3.2 Market Dynamics 3.2.1 Market Driver Analysis Continue…………. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com